These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17268057)

  • 1. Preservative effect of electrolyzed reduced water on pancreatic beta-cell mass in diabetic db/db mice.
    Kim MJ; Jung KH; Uhm YK; Leem KH; Kim HK
    Biol Pharm Bull; 2007 Feb; 30(2):234-6. PubMed ID: 17268057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice.
    Kim MJ; Kim HK
    Life Sci; 2006 Nov; 79(24):2288-92. PubMed ID: 16945392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism by which pioglitazone preserves pancreatic beta-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARgamma agonist.
    Kanda Y; Shimoda M; Hamamoto S; Tawaramoto K; Kawasaki F; Hashiramoto M; Nakashima K; Matsuki M; Kaku K
    Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E278-86. PubMed ID: 19920213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice.
    Okauchi S; Shimoda M; Obata A; Kimura T; Hirukawa H; Kohara K; Mune T; Kaku K; Kaneto H
    Biochem Biophys Res Commun; 2016 Feb; 470(3):772-782. PubMed ID: 26505796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes.
    Yoshida S; Tanaka H; Oshima H; Yamazaki T; Yonetoku Y; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Oct; 400(4):745-51. PubMed ID: 20816753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
    Harrity T; Farrelly D; Tieman A; Chu C; Kunselman L; Gu L; Ponticiello R; Cap M; Qu F; Shao C; Wang W; Zhang H; Fenderson W; Chen S; Devasthale P; Jeon Y; Seethala R; Yang WP; Ren J; Zhou M; Ryono D; Biller S; Mookhtiar KA; Wetterau J; Gregg R; Cheng PT; Hariharan N
    Diabetes; 2006 Jan; 55(1):240-8. PubMed ID: 16380499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Diabetic Activities of Gastrodia elata Blume Water Extracts Are Mediated Mainly by Potentiating Glucose-Stimulated Insulin Secretion and Increasing β-Cell Mass in Non-Obese Type 2 Diabetic Animals.
    Yang HJ; Kim MJ; Kwon DY; Kim DS; Lee YH; Kim JE; Park S
    Nutrients; 2016 Mar; 8(3):161. PubMed ID: 26978400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DC260126: a small-molecule antagonist of GPR40 that protects against pancreatic β-Cells dysfunction in db/db mice.
    Sun P; Wang T; Zhou Y; Liu H; Jiang H; Zhu W; Wang H
    PLoS One; 2013; 8(6):e66744. PubMed ID: 23776696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SGLT2 knockout prevents hyperglycemia and is associated with reduced pancreatic β-cell death in genetically obese mice.
    Jurczak MJ; Saini S; Ioja S; Costa DK; Udeh N; Zhao X; Whaley JM; Kibbey RG
    Islets; 2018; 10(5):181-189. PubMed ID: 30118626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel GPR119 agonist AS1669058 potentiates insulin secretion from rat islets and has potent anti-diabetic effects in ICR and diabetic db/db mice.
    Oshima H; Yoshida S; Ohishi T; Matsui T; Tanaka H; Yonetoku Y; Shibasaki M; Uchiyama Y
    Life Sci; 2013 Feb; 92(2):167-73. PubMed ID: 23246743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary restriction preserves the mass and function of pancreatic β cells via cell kinetic regulation and suppression of oxidative/ER stress in diabetic mice.
    Kanda Y; Hashiramoto M; Shimoda M; Hamamoto S; Tawaramoto K; Kimura T; Hirukawa H; Nakashima K; Kaku K
    J Nutr Biochem; 2015 Mar; 26(3):219-26. PubMed ID: 25488546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats.
    Arya A; Looi CY; Cheah SC; Mustafa MR; Mohd MA
    J Ethnopharmacol; 2012 Oct; 144(1):22-32. PubMed ID: 22954496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats.
    Jahan H; Choudhary MI; Manzoor M; Khan KM; Perveen S; Atta-Ur-Rahman
    Chem Biol Interact; 2017 Aug; 273():237-244. PubMed ID: 28625491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetes.
    Kimura T; Kaneto H; Shimoda M; Hirukawa H; Okauchi S; Kohara K; Hamamoto S; Tawaramoto K; Hashiramoto M; Kaku K
    Mol Cell Endocrinol; 2015 Jan; 400():78-89. PubMed ID: 25463759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
    Moon H; Chon J; Joo J; Kim D; In J; Lee H; Park J; Choi J
    Diabetes Metab Res Rev; 2013 Jan; 29(1):19-24. PubMed ID: 22936676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ezetimibe on insulin secretion in db/db diabetic mice.
    Zhong Y; Wang J; Gu P; Shao J; Lu B; Jiang S
    Exp Diabetes Res; 2012; 2012():420854. PubMed ID: 23118741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astaxanthin protects beta-cells against glucose toxicity in diabetic db/db mice.
    Uchiyama K; Naito Y; Hasegawa G; Nakamura N; Takahashi J; Yoshikawa T
    Redox Rep; 2002; 7(5):290-3. PubMed ID: 12688512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.